BIO-key to Participate in CIO Forum Panel and Showcase its PortalGuard Identity and Access Management Platform at National Association of Counties Conference July 20-24
VP of Product Kimberly Biddings is an Expert Panelist in “A Crash Course in Marketing – Communicating About Cybersecurity Across Your County” during the CIO Forum on Weds.
AURORA, Colo. and WALL, N.J., July 14, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, announced today that it will sponsor and exhibit at the at the Gaylord Rockies Resort and Convention Center in Aurora, Colorado, July 20-24th. BIO-key will meet with customer prospects and host Q&A sessions, and live demonstrations of their award-winning IAM platform at Booth 507. BIO-key’s VP of Product, Kimberly Biddings, will be a featured expert panelist in “A Crash Course in Marketing – Communicating About Cybersecurity Across Your County” during NACo’s on Wednesday, July 20th.
Counties carry the significant responsibility of keeping resident personal information, priceless historical records, and critical infrastructure protected and secure in the event of a security breach. Over the past few years, counties have faced hundreds of cyberattacks that threaten their residents and critical infrastructure, including 911 call centers and water treatment plants. For another consecutive year this has elevated cybersecurity to a top priority for attendees at the conference, with multi-factor authentication (MFA) remaining at the top of the .
“For the second year in a row we are excited to sponsor and attend this event at a critical time when cybersecurity is top of mind for all counties,” said Fred Corsentino, Chief Revenue Officer of BIO-key. “Counties are an integral part of our national infrastructure and as an active partner to NACo member counties, we look forward to helping County IT leaders implement stronger IAM controls and to discussing cybersecurity measures that are essential to keeping their constituents safe from increasing cyberattacks.”
Attendees are invited to stop by booth 507 for live demonstrations of BIO-key’s PortalGuard solutions and to discuss their cybersecurity priorities, including:
- Implementing multi-factor authentication, including biometrics;
- Securing remote access;
- Eliminating passwords with single sign-on;
- Election security; and
- Security policy configuration.
During demonstrations, attendees will see why PortalGuard stands out for its ability to help counties implement a complete IAM strategy. PortalGuard is the only IAM platform to offer Identity-Bound Biometric (IBB) authentication as part of its multi-factor authentication capabilities, which uses a unique, centralized biometric identity to verify the person – not just a password, token, or device. The platform offers unmatched flexibility to support solution consolidation and aggregation under one set of centrally managed security policies and drive better user adoption. PortalGuard is affordable for counties of all sizes, offering all capabilities of the platform often at 50-60% below the competition, and is backed by a team of IAM experts, who are easy to reach and act as an extension of the county's IT team, thereby improving their cybersecurity posture quickly.
To learn more about BIO-key’s IAM solutions for counties, .
About BIO-key International, Inc. ()
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors'' in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.
Engage with BIO-key
Facebook – Corporate:
LinkedIn – Corporate:
Twitter – Corporate:
Twitter – Investors:
StockTwits:
Media Contact
Erin Knapp
Matter on behalf of BIO-key
Investor Contacts
William Jones, David Collins
Catalyst IR
212-924-9800
